Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
- Market Realist•yesterday
US corporates dominated the primary market for high-grade bonds in the week ending July 22—making up 52.8% or $16.0 billion of all the issues.
Teva Pharmaceutical Industries LimitedNYSE
Pre-Market: 54.70-0.09 (-0.16%) as of 8:49 AM EDT
|Bid||54.70 x 2700|
|Ask||55.20 x 200|
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||6,217,103|
As of 4:02 PM EDT. Market closed.